[The use of high-dose cyclophosphamide in the treatment of human solid tumors].
D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001237:Asphyxia / Q000517:prevention & control; D001772:Blood Cell Count; D001943:Breast Neoplasms / Q000188:drug therapy; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002276:Carcinoid Tumor / Q000188:drug therapy; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D003036:Cobalt Isotopes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D005938:Glucocorticoids / Q000627:therapeutic use; D007120:Immunochemistry; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008479:Mediastinal Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D011877:Radionuclide Imaging; D011882:Radiotherapy, High-Energy; D014134:Tracheal Neoplasms / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D003036:Cobalt Isotopes; D005938:Glucocorticoids; D003520:Cyclophosphamide
Emploi de la cyclophosphamide à doses massives dans le traitement des tumeurs solides humaines.